MFIM
MGNX icon

Mesirow Financial Investment Management’s MacroGenics MGNX Stock Holding History

Mesirow Financial Investment Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,439
Closed -$267K – 63
2018
Q3 		$267K Sell
12,439
-963
-7% -$20.5K 1.38% 42
2018
Q2 		$277K Sell
13,402
-2,172
-14% -$48.9K 1.23% 44
2018
Q1 		$392K Sell
15,574
-230
-1% -$5.59K 1.65% 28
2017
Q4 		$300K Buy
15,804
+57
+0.4% +$1.06K 1.36% 44
2017
Q3 		$291K Buy
+15,747
New +$273K 1.37% 45

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
CPV Partners Stamford, Connecticut $224M AUM 77.2% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Mesirow Financial Investment Management's MGNX Position: Q4 2018 in Review

Mesirow Financial Investment Management sold out of MacroGenics (MGNX) in Q4 2018, closing a stake of 12,439 shares — an estimated $267K sold.

Mesirow Financial Investment Management first reported a position in MGNX in Q3 2017 and held it in 5 quarters. The position peaked at $392K in Q1 2018. 133 funds tracked by Wall St. Rank hold MGNX as of Q4 2018.

  • Mesirow Financial Investment Management reported no remaining MacroGenics position as of Q4 2018 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 12,439 MacroGenics shares in Q4 2018, an estimated $267K.
  • Mesirow Financial Investment Management first reported a position in MacroGenics in Q3 2017 and held it in 5 quarters.
  • Mesirow Financial Investment Management's MacroGenics position peaked at $392K in Q1 2018.
  • 133 funds tracked by Wall St. Rank held MacroGenics as of Q4 2018.

Based on Mesirow Financial Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.